{"webUser":null,"request_id":"48a0ede70a1ed80b64cb2b3c5c4d5a37"}
{"flashNotices":[],"request_id":"48a0ede70a1ed80b64cb2b3c5c4d5a37"}

Pharma Pulse / Pharma Pulse: FDA Grants Priority Review to Rusfertide and Expands Approval for Novo Nordisk’s Sogroya

View our embed guidelines

Sorry, your browser isn't supported.

We recommend upgrading to the latest Chrome, Firefox, Safari, or Edge.

You can visit our support center if you're having problems.